Clinical Report: Advancements in Understanding Targeted Regulatory Proteins for Atherosclerosis Prevention and Treatment
Overview
This review highlights the roles of key regulatory proteins in atherosclerosis (AS) pathogenesis, emphasizing the interplay between epigenetic modifiers, transcription factors, and membrane signaling axes.
Background
Atherosclerosis is a chronic inflammatory disease that significantly contributes to cardiovascular morbidity and mortality. The disease process involves complex interactions between immune and vascular cells, driven by metabolic dysregulation and inflammation.
Data Highlights
No numerical data or trial data were provided in the source material.
Key Findings
Epigenetic modifiers like histone deacetylases (HDACs) and TET2 play critical roles in remodeling chromatin to activate pro-inflammatory gene programs.
Transcription factors such as KLFs, PPARs, and Nrf2 are essential for linking metabolic homeostasis with anti-inflammatory responses.
Membrane signaling axes, including Eph receptors and the SIRPα-CD47 checkpoint, significantly influence endothelial dysfunction and macrophage polarization.
HDAC3 has a dual role in macrophage polarization, exacerbating inflammation in diabetic atherosclerotic plaques.
UCP and ANGPTL proteins contribute to cellular metabolism and inflammasome regulation, impacting atherosclerotic processes.
Clinical Implications
Understanding the regulatory proteins involved in atherosclerosis can inform the development of targeted therapies aimed at modulating inflammatory responses and metabolic dysregulation.
Conclusion
The comprehensive elucidation of immuno-vascular networks in atherosclerosis is vital for understanding the mechanisms of cardiovascular disease.
New studies separate host and microbial metabolites, trace secreted proteins, identify a pro-regenerative cardiomyocyte state, and map macrophage lipid metabolism
